Blood Cancer Journal (Nov 2024)
Genetically determined telomere length in monoclonal gammopathy of undetermined significance, multiple myeloma risk and outcome
- Matteo Giaccherini,
- Alyssa I. Clay-Gilmour,
- Romano Liotti,
- Angelica Macauda,
- Manuel Gentiluomo,
- Elizabeth E. Brown,
- Mitchell J. Machiela,
- Stephen J. Chanock,
- Michelle A. T. Hildebrandt,
- Aaron D. Norman,
- Elisabet Manasanch,
- S. Vincent Rajkumar,
- Jonathan N. Hofmann,
- Sonja I. Berndt,
- Parveen Bhatti,
- Graham G. Giles,
- Elad Ziv,
- Shaji K. Kumar,
- Nicola J. Camp,
- Wendy Cozen,
- Susan L. Slager,
- Federico Canzian,
- Federica Gemignani,
- Celine M. Vachon,
- Daniele Campa
Affiliations
- Matteo Giaccherini
- Department of Biology, University of Pisa
- Alyssa I. Clay-Gilmour
- Department of Biostatistics & Epidemiology, Arnold School of Public Health, University of South Carolina
- Romano Liotti
- Department of Biology, University of Pisa
- Angelica Macauda
- Genomic Epidemiology Group, German Cancer Research Center (DKFZ)
- Manuel Gentiluomo
- Department of Biology, University of Pisa
- Elizabeth E. Brown
- Department of Pathology, Heersink School of Medicine, University of Alabama
- Mitchell J. Machiela
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health
- Stephen J. Chanock
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health
- Michelle A. T. Hildebrandt
- Division of Cancer Medicine, Department of Lymphoma - Myeloma, The University of Texas MD Anderson Cancer Center
- Aaron D. Norman
- Division of Epidemiology, Department of Quantitative Health Sciences, Mayo Clinic
- Elisabet Manasanch
- Division of Cancer Medicine, Department of Lymphoma - Myeloma, The University of Texas MD Anderson Cancer Center
- S. Vincent Rajkumar
- Division of Hematology, Department of Internal Medicine, Mayo Clinic
- Jonathan N. Hofmann
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health
- Sonja I. Berndt
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health
- Parveen Bhatti
- Cancer Control Research, BC Cancer
- Graham G. Giles
- Cancer Epidemiology Division, Cancer Council Victoria
- Elad Ziv
- Department of Medicine, University of California San Francisco Helen Diller Family Comprehensive Cancer Center
- Shaji K. Kumar
- Division of Hematology, Department of Internal Medicine, Mayo Clinic
- Nicola J. Camp
- Division of Hematology and Huntsman Cancer Institute, University of Utah
- Wendy Cozen
- Division of Hematology/Oncology, Department of Medicine, School of Medicine, Department of Pathology, School of Medicine, Susan and Henry Samueli College of Health Sciences, Chao Family Comprehensive Cancer Center, University of California at Irvine
- Susan L. Slager
- Division of Hematology, Department of Internal Medicine, Mayo Clinic
- Federico Canzian
- Genomic Epidemiology Group, German Cancer Research Center (DKFZ)
- Federica Gemignani
- Department of Biology, University of Pisa
- Celine M. Vachon
- Division of Epidemiology, Department of Quantitative Health Sciences, Mayo Clinic
- Daniele Campa
- Department of Biology, University of Pisa
- DOI
- https://doi.org/10.1038/s41408-024-01181-w
- Journal volume & issue
-
Vol. 14,
no. 1
pp. 1 – 5
Abstract
No abstracts available.